STAT3 and SPI1, may lead to the immune system dysregulation and heterotopic ossification in ankylosing spondylitis

被引:0
|
作者
Tuo Liang
Jiarui Chen
GuoYong Xu
Zide Zhang
Jiang Xue
Haopeng Zeng
Jie Jiang
Tianyou Chen
Zhaojie Qin
Hao Li
Zhen Ye
Yunfeng Nie
Xinli Zhan
Chong Liu
机构
[1] The First Affiliated Hospital of Guangxi Medical University,Spine and Osteopathy Ward
[2] Guangxi Medical University,undefined
来源
关键词
Ankylosing spondylitis; Th1 cells; NKT cells; STAT3; SPI1; Biomarkers;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 10 条
  • [1] STAT3 and SPI1, may lead to the immune system dysregulation and heterotopic ossification in ankylosing spondylitis
    Liang, Tuo
    Chen, Jiarui
    Xu, GuoYong
    Zhang, Zide
    Xue, Jiang
    Zeng, Haopeng
    Jiang, Jie
    Chen, Tianyou
    Qin, Zhaojie
    Li, Hao
    Ye, Zhen
    Nie, Yunfeng
    Zhan, Xinli
    Liu, Chong
    BMC IMMUNOLOGY, 2022, 23 (01)
  • [2] STAT1/STAT3 Gain of Function and Mechanisms of Immune Dysregulation
    Kiykim, Ayca
    TURKISH JOURNAL OF IMMUNOLOGY, 2024, 12 : 47 - 52
  • [3] Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese
    Davidson, Stuart I.
    Liu, Yu
    Danoy, Patrick A.
    Wu, Xin
    Thomas, Gethin P.
    Jiang, Lei
    Sun, Linyun
    Wang, Niansong
    Han, Jun
    Han, Huanxing
    Visscher, Peter M.
    Brown, Matthew A.
    Xu, Huji
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (02) : 289 - 292
  • [4] Association of Variants at 1q32 and STAT3 with Ankylosing Spondylitis Suggests Genetic Overlap with Crohn's Disease
    Danoy, Patrick
    Pryce, Karena
    Hadler, Johanna
    Bradbury, Linda A.
    Farrar, Claire
    Pointon, Jennifer
    Ward, Michael
    Weisman, Michael
    Reveille, John D.
    Wordsworth, B. Paul
    Stone, Millicent A.
    Maksymowych, Walter P.
    Rahman, Proton
    Gladman, Dafna
    Inman, Robert D.
    Brown, Matthew A.
    PLOS GENETICS, 2010, 6 (12) : 1 - 5
  • [5] Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations
    Forbes, Lisa R.
    Vogel, Tiphanie P.
    Cooper, Megan A.
    Castro-Wagner, Johana
    Schussler, Edith
    Weinacht, Katja G.
    Plant, Ashley S.
    Su, Helen C.
    Allenspach, Eric J.
    Slatter, Mary
    Abinun, Mario
    Lilic, Desa
    Cunningham-Rundles, Charlotte
    Eckstein, Olive
    Olbrich, Peter
    Guillerman, R. Paul
    Patel, Niraj C.
    Demirdag, Yesim Y.
    Zerbe, Christa
    Freeman, Alexandra F.
    Holland, Steven M.
    Szabolcs, Paul
    Gennery, Andrew
    Torgerson, Troy R.
    Milner, Joshua D.
    Leiding, Jennifer W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (05) : 1665 - 1669
  • [6] In vitro Characterization of Two STAT3 Gain of Function Mutations Associated with IGF-1 Deficiency and Immune Dysregulation
    Gutierrez, M.
    Scaglia, P.
    Keselman, A.
    Martucci, L.
    Karabatas, L.
    Domene, S.
    Blanco, M.
    Sanguinetti, N.
    Bezrodnik, L.
    Di Giovanni, D.
    Caldirola, S.
    Esnaola Azcoiti, M.
    Jones, N.
    Hwa, V
    Revale, S.
    Vazquez, M.
    Jasper, H.
    Kumar, A.
    Domene, H.
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 11 - 11
  • [7] EIF4A3 induced circABCA5 promotes the gastric cancer progression by SPI1 mediated IL6/JAK2/STAT3 signaling
    Hou, Guowei
    Zuo, Hao
    Shi, Jin
    Dai, Dezhu
    Wang, Haixiao
    Song, Xudong
    Xu, Guo
    Tao, Guoquan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (02): : 602 - 622
  • [8] m6A-modified circSTX6 as a key regulator of cervical cancer malignancy via SPI1 and IL6/JAK2/STAT3 pathways
    Han, Xiaotian
    Xia, Lingfang
    Wu, Yong
    Chen, Xiaojun
    Wu, Xiaohua
    ONCOGENE, 2025, : 968 - 982
  • [9] miR-21 may Act as a Potential Mediator Between Inflammation and Abnormal Bone Formation in Ankylosing Spondylitis Based on TNF-α Concentration-Dependent Manner Through the JAK2/STAT3 Pathway
    Zou, Yu-Cong
    Yan, Li-Man
    Gao, Yan-Ping
    Wang, Zhi-Yun
    Liu, Gang
    DOSE-RESPONSE, 2020, 18 (01):
  • [10] Sunitinib inhibits PD-L1 expression in osteosarcoma by targeting STAT3 and remodels the immune system in tumor-bearing mice
    Duan, Xian Liang
    Guo, Jian Ping
    Li, Fan
    Xiu, Chao
    Wang, Hua
    FUTURE ONCOLOGY, 2020, 16 (24) : 1815 - 1824